ATRX (ATR-X, X-linked helicase II, XH2, X-linked nuclear protein gene, XNP) Gene Mutation Analysis


Alpha Thalassemia/Mental Retardation Syndrome
Smith-Fineman-Myers Syndrome (SFM)
Carpenter-Waziri Syndrome (CWS)
Juberg-Marsidi Syndrome (JM)
Alpha Thalassemia Myelodysplasia Syndrome (ATMDS) 
 
ATRX (ATR-X, X-linked helicase II, XH2, X-linked nuclear protein gene, XNP) belongs to the SNF2 family of proteins, many of which have been demonstrated to have chromatin remodeling activity. ATRX gene spans about 300kb of genomic DNA and contains 36 exons. Mutations in the transcriptional regulator ATRX are associated with several X-linked mental retardation syndromes: (1) X-linked alpha-thalassemia/mental retardation syndrome (ATR-X) characterized by severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, alpha-thalassemia, and hemoglobin H erythrocyte inclusions, an essential phenotypic trait1; (2) Smith-Fineman-Myers syndrome (SFM) with clinical features including severe mental retardation, microcephaly, growth failure, facial anomalies and bilateral cryptorchidism2; (3) Carpenter-Waziri syndrome (CWS) characterized by moderate mental retardation, short stature, brachydactyly with excessive skin creases, and widening of the knuckles3; (4) Juberg-Marsidi syndrome (JM) characterized by severe mental retardation, growth failure, sensorineural deafness, microgenitalism and early death4; and (5) alpha-thalassemia myelodysplasia syndrome (ATMDS) in which alpha-thalassemia occurs as an acquired abnormality in association with a multilineage myelodysplasia5. Over 200 cases from 182 families have been identified with 113 different mutations6.

To open a printable assay summary in a new window, click the link below.

ATRX Gene Mutation Analysis Assay Summary
(in portable document format (pdf) which requires Adobe® Acrobat® Reader™ to view or print; download latest version free)

Please submit the Test Request Form (TRF) and the Neuropsychiatric Patient Information Form when ordering this test.

References
1. Gibbons RJ, et al. Cell. 1995 Mar 24;80(6):837-45.
2. Villard L, et al. Am J Med Genet. 2000 Mar 6;91(1):83-5.
3. Abidi F, et al. Am J Med Genet. 1999 Jul 30;85(3):249-51.
4. Villard L, et al. Nat Genet. 1996 Apr;12(4):359-60.
5. Gibbons RJ, et al. Nat Genet. 2003 Aug;34(4):446-9.
6. Gibbons RJ, et al. Hum Mutat 2008; 29(6), 796–802. 

Back to the List of Services

Neuropsychiatric Diseases

NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.